Bethanee Schlosser is a Dermatology physician affiliated with AbbVie. OpenAlex indexes 86 publications with 2,899 citations (h-index 19); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
676 North St. Clair Street
Suite 1600
Chicago, IL 60611
Telephone
312-695-8106Registry record last updated 19 Jun 2013.
Clinical trials
- Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function
Sponsor: Northwestern University
- Vulvar Mucosal Specialty Clinic Chart Review
Sponsor: Northwestern University
- Vulvar Scarring Grading Scale for Lichen Sclerosus
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
39%Estrogen39%Estradiol100%Part D≥21 patientsAnti-infectives
29.1%Nitroimidazole Antimicrobial11.3%Metronidazole100%Part D<11 patientsAzole Antifungal9.9%Ketoconazole100%Part D<11 patients+ 1 more class in this area
Sensory organs
22%Corticosteroid22%Clobetasol Propionate100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo
Journal of Investigative Dermatology
2026 - Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”